Literature DB >> 22144727

Statins lower calcium-induced oxidative stress in isolated mitochondria.

A Parihar1, M S Parihar, W J Zenebe, P Ghafourifar.   

Abstract

Statins are widely used cholesterol-lowering agents that exert cholesterol-independent effects including antioxidative. The present study delineates the effects of statins, atorvastatin, and simvastatin on oxidative stress and functions of mitochondria that are the primary cellular sources of oxidative stress. In isolated rat liver mitochondria, both the statins prevented calcium-induced cytochrome c release, lipid peroxidation, and opening of the mitochondrial membrane permeability transition (MPT). Both the statins decreased the activity of mitochondrial nitric oxide synthase (mtNOS), lowered the intramitochondrial ionized calcium, and increased the mitochondrial transmembrane potential. Our findings suggest that statins lower intramitochondrial ionized calcium that decreases mtNOS activity, lowers oxidative stress, prevents MPT opening, and prevents the release of cytochrome c from the mitochondria. These results provide a novel framework for understanding the antioxidative properties of statins and their effects on mitochondrial functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22144727     DOI: 10.1177/0960327111429141

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  7 in total

1.  Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials.

Authors:  Emil List Larsen; Vanja Cejvanovic; Laura Kofoed Kjaer; Morten Thorup Pedersen; Sara Daugaard Popik; Lina Kallehave Hansen; Jon Traerup Andersen; Espen Jimenez-Solem; Kasper Broedbaek; Morten Petersen; Allan Weimann; Trine Henriksen; Jens Lykkesfeldt; Christian Torp-Pedersen; Henrik Enghusen Poulsen
Journal:  Br J Clin Pharmacol       Date:  2017-03-17       Impact factor: 4.335

Review 2.  Mitochondria and cardiovascular diseases-from pathophysiology to treatment.

Authors:  Gerasimos Siasos; Vasiliki Tsigkou; Marinos Kosmopoulos; Dimosthenis Theodosiadis; Spyridon Simantiris; Nikoletta Maria Tagkou; Athina Tsimpiktsioglou; Panagiota K Stampouloglou; Evangelos Oikonomou; Konstantinos Mourouzis; Anastasios Philippou; Manolis Vavuranakis; Christodoulos Stefanadis; Dimitris Tousoulis; Athanasios G Papavassiliou
Journal:  Ann Transl Med       Date:  2018-06

3.  Lovastatin as an adjuvant to lithium for treating manic phase of bipolar disorder: a 4-week, randomized, double-blind, placebo-controlled clinical trial.

Authors:  Ahmad Ghanizadeh; Motahhar OmraniSigaroodi; Ali Javadpour; Mohammad Hossein Dabbaghmanesh; Sara Shafiee
Journal:  Depress Res Treat       Date:  2014-07-15

4.  Simvastatin attenuates chromium-induced nephrotoxicity in rats.

Authors:  Zahra Goodarzi; Esmaeil Karami; Massumeh Ahmadizadeh
Journal:  J Nephropathol       Date:  2016-08-09

Review 5.  Antioxidants and Dementia Risk: Consideration through a Cerebrovascular Perspective.

Authors:  Virginie Lam; Mark Hackett; Ryusuke Takechi
Journal:  Nutrients       Date:  2016-12-20       Impact factor: 5.717

6.  Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial.

Authors:  Sanne Tofte Rasmussen; Jon Trærup Andersen; Torben Kjær Nielsen; Vanja Cejvanovic; Kasper Meidahl Petersen; Trine Henriksen; Allan Weimann; Jens Lykkesfeldt; Henrik Enghusen Poulsen
Journal:  Redox Biol       Date:  2016-05-30       Impact factor: 11.799

7.  Coenzyme Q10 or Creatine Counteract Pravastatin-Induced Liver Redox Changes in Hypercholesterolemic Mice.

Authors:  Ana C Marques; Estela N B Busanello; Diogo N de Oliveira; Rodrigo R Catharino; Helena C F Oliveira; Anibal E Vercesi
Journal:  Front Pharmacol       Date:  2018-06-27       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.